Stay updated on Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial

Sign up to get notified when there's something new on the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2025-03-11T05:20:52.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T22:09:12.000Z thumbnail image
  5. Check
    32 days ago
    No Change Detected
  6. Check
    39 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    2%
    Check dated 2025-02-10T14:48:51.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T10:15:24.000Z thumbnail image
  8. Check
    53 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2025-01-27T04:27:06.000Z thumbnail image
  9. Check
    60 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-20T01:46:56.000Z thumbnail image

Stay in the know with updates to Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page.